BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37935218)

  • 1. A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis.
    Wang Y; Ming G; Gao B
    Acta Orthop Belg; 2023 Sep; 89(3):373-380. PubMed ID: 37935218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.
    Sun B; Wang F; Li M; Yang M
    Med Oncol; 2015 May; 32(5):153. PubMed ID: 25832865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
    Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
    Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma.
    Sun W; Ma X; Shen J; Yin F; Wang C; Cai Z
    Int J Mol Med; 2016 Aug; 38(2):466-74. PubMed ID: 27353415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning and experimental validation to construct a metastasis-related gene signature and ceRNA network for predicting osteosarcoma prognosis.
    Liao Y; Liu Q; Xiao C; Zhou J
    J Orthop Surg Res; 2022 Dec; 17(1):516. PubMed ID: 36457129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.
    Chen G; Wang Q; Yang Q; Li Z; Du Z; Ren M; Zhao H; Song Y; Zhang G
    PLoS One; 2018; 13(8):e0202896. PubMed ID: 30153287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
    Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis.
    Li G; Huang B; Wu H; Zhang H
    Transl Cancer Res; 2022 Jul; 11(7):2374-2387. PubMed ID: 35966307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma.
    Gong J; Tang W; Lv B; Zhang S; Fan T; Gao G; Chen D; Liu Y
    Biomed Res Int; 2021; 2021():3381957. PubMed ID: 34350290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.